PAREXEL International
PAREXEL International Reports Second Quarter Fiscal Year 2014 Results
01.29.14
PAREXEL International Second Quarter Fiscal Year 2014 Results were announced and for the three months ended December 31, 2013 consolidated service revenue increased by 15.4% to $487.1 million. Read Full Release
Odyssey Logistics & Technology
Boston Millennia Portfolio Company, Odyssey Logistics & Technology, Inc., Announces Achievement of Double-Digit, Year-Over-Year Growth for 2013
02.04.14
Odyssey Logistics & Technology, a global supply chain logistics services provider, announced achieving double-digit, year-over-year growth of 32% in 2013. Read Full Release
MedAptus
Boston Millennia Portfolio Company, MedAptus®, Earns #1 Ranking from KLAS, Fourth Year in a Row
02.04.14
MedAptus® today announced that its Professional Charge Capture (Pro) solution has been named the Category Leader in the Mobile Data Systems segment in the “2013 Best in KLAS: Software & Services” report, marking the fourth consecutive year that MedAptus has received the distinction. Read Full Release
Boston Millennia Partners
Boston Millennia Partners Portfolio Company, PreCision Dermatology, Acquires Rights to Clindagel®
10.30.13
Onset Dermatologics, a PreCision Dermatology company and a leader in developing and commercializing prescription products for improving skin health, today announced the acquisition of Clindagel® from Galderma Laboratories. Read Full Release
MedAptus
Boston Millennia Portfolio Company, MedAptus, Featured in Recent HIStalk Blog
08.30.13
Ryan Secan, MD, MPH, Chief Medical Officer of MedAptus, Inc., a Boston Millennia portfolio company, was published on HIStalk for his comments on product development in health care technology. Read Full Release
Histogenics
Boston Millennia Portfolio Company, Histogenics Corp., Announces Key Additions to Management Team
08.20.13
Histogenics Corp. announced the addition of Stephen Kennedy as Senior Vice President of Manufacturing, Operations, and Supply Chain, and Vladimir Scerbin as Vice President of Clinical Affairs. Read Full Release
Nexidia, Inc.
Boston Millennia Portfolio Company, Nexidia, Recognized by Speech Technology Magazine
08.14.13
Nexidia was named Speech Analytics Market Winner for seventh consecutive year by Speech Technology Magazine. Read Full Release
Odyssey Logistics & Technology
Boston Millennia Portfolio Company, Odyssey Logistics, Recognized by Inbound Logistics Magazine
08.12.13
Odyssey Logistics has been named a 2013 Top 100 3PL Logistics Provider by Inbound Logistics Magazine for the ninth consecutive year. Read Full Release
PAREXEL International
PAREXEL International Reports Fourth Quarter And Fiscal Year 2013 Results
08.08.13
PAREXEL International Corp. (NASDAQ: PRXL) reported financial results for the fourth quarter and Fiscal Year 2013. For the three months ended June 30, 2013 consolidated service revenue increased by 18% to $463.1 million compared with $392.6 million in the prior year period. Read Full Release
PHT Corp
Boston Millennia Portfolio Company, PHT Corp., Names Steve Rosenberg Chief Operating Officer
06.24.13
PHT Corp., has named software industry veteran executive, Steve Rosenberg, Chief Operating Officer. Steve brings over 30 years of experience in operations, most recently as Vice President of Software and Services, Health Sciences Global Business Unit (HSGBU) at Oracle Corporation. Read Full Release
Histogenics
Boston Millennia Portfolio Company, Histogenics Corp., Announces Peter Greenleaf as CEO
06.10.13
Histogenics Corp. has announced the appointment of Peter Greenleaf to Chief Executive Officer. Mr. Greenleaf brings over 20 years of experience in the biotechnology industry, most recently as President of MedImmune, the worldwide biologics arm of AstraZeneca. Read Full Release
Collegium Pharmaceutical
Boston Millennia Portfolio Company, Collegium Pharmaceutical, Featured in Wall Street Journal
05.06.13
Collegium Pharmaceutical was featured in a Wall Street Journal article discussing the innovative technologies being developed in the painkiller market to make drugs more abuse-deterrent. Read Full Release
Odyssey Logistics & Technology
Boston Millennia Portfolio Company, Odyssey Logistics & Technology, Acquires Hawaii Intermodal Tank Transport
06.06.13
Odyssey Logistics & Technology, Inc. has announced the acquisition of Hawaii Intermodal Tank Transport, a leading operator of intermodal tanks with the largest fleet of refrigerated ISO Tanks exclusively used to move food-grade products. This marks Odyssey’s 10th acquisition since inception. Read Full Release
MedAptus
Boston Millennia Portfolio Company, MedAptus®, is Featured in an Article in the May Issue of Group Practice Journal
05.21.13
Boston Millennia Portfolio Company, MedAptus®, is featured in an article in Group Practice Journal, discussing the successful implementation of MedAptus® charge capture software across IHA, one of Michigan's largest group practices. Read Full Release
iParty
Boston Millennia Partners Portfolio Company, iParty, Announces Completion of Acquisition by Party City Holdings, Inc.
05.09.13
Boston Millennia Portfolio Company, iParty, a leading party goods retailer with a strong presence in New England, today announced the completion of its acquisition by Party City, North America's largest party supply retailer. Read Full Release
Odyssey Logistics & Technology
Boston Millennia Portfolio Company, Odyssey Logistics & Technology Corporation, Continues Double-Digit Growth Trend
04.24.13
Millennia portfolio company, Odyssey Logistics & Technology, announced another consecutive quarter of double-digit growth. Read Full Release
MedAptus
Boston Millennia Portfolio Company, MedAptus®, Announces UMass Memorial Health to Use the Company’s Technical Charge Capture Software
04.24.13
Millennia portfolio company, MedAptus, announced today that UMass Memorial Health, the largest health care system in central and western Massachusetts and clinical partner of the University of Massachusetts Medical School, will use their Technical Charge Capture to standardize management. Read Full Release
Collegium Pharmaceutical
Boston Millennia Partners Portfolio Company, Collegium Pharmaceuticals, Announces Successful Completion of Clinical Study
04.17.13
Millennia Portfolio Company, Collegium Pharmaceuticals, announced today the top-line results from its completed Phase I clinical trial for Oxycodone DETERx®, its extended-release, abuse-deterrent, multi-particulate product in a capsule form. Read Full Release
iParty
Boston Millennia Partners Portfolio Company, iParty, to be Acquired by Party City Holdings, Inc.
03.01.13
Boston Millennia Portfolio Company, iParty, a leading party goods retailer with a strong presence in New England, will be acquired by Party City Holdings, Inc., North America’s largest party supply retailer. The transaction is currently expected to close during the second quarter of 2013. Read Full Release
Odyssey Logistics & Technology
Millennia Portfolio Company, Odyssey Logistics & Technology Grew Earnings More Than 50% in 2012
02.07.13
Millennia Portfolio Company, Odyssey Logistics & Technology announced today that their earnings grew more than 50% in 2012 by expansion in both the domestic and international market to support their global customers. Read Full Release